Best of ASCO - 2014 Annual Meeting



Local-Regional Therapy

Breast Cancer—Local/Regional/Adjuvant

2019 ASCO Annual Meeting

Sort by: title abstract no. first author
“Good Risk”: low-risk patients with ductal carcinoma in situ (DCIS) benefit from whole breast radiotherapy after breast conservation surgery (BCS)–long-term follow-up.

Anna Niwinska


A prospective study to evaluate the accuracy of axillary staging using ultrasound and USG-guided fine needle aspiration cytology in early breast cancer patients in a high-volume center.

Rashpal Singh


A prospective validation cohort study of a prediction model on non-sentinel lymph node involvement in early breast cancer.

Xingfei Yu


Accelerated partial breast irradiation (APBI) using intensity modulated radiation therapy (IMRT) in stage 0-II breast cancer: A preliminary report of 57 cases.

Rufus J. Mark


Association between tumor biology and occult lymph node metastases before and after primary neoadjuvant therapy (NAT) for patients with early breast cancer.

Hans-Christian Kolberg


Automated artificial intelligence quantification of fibroglandular tissue on breast MRI.

Ruquaiyah Takhtawala


Breast cancer treatment according to pathogenic variants in cancer susceptibility genes in a population-based cohort.

Allison W. Kurian


Cctg MA.39 tailor RT: A randomized trial of regional radiotherapy in biomarker low-risk node-positive breast cancer (NCT03488693).

Wendy R. Parulekar


Circulating tumor cells in patients with locally advanced breast cancer in evaluation of antitumor treatment efficacy.

Aleksandr B. Sagakyants


Clinical relevance of 21-gene recurrence score with lymph node involvement in HR+HER2- early breast cancer: A tumor size-match paired cohort study.

Xingfei Yu


Cognitive impairment in breast cancer patients before surgery?: Results of a subgroup of the French CANTO cohort.

Marie Lange


Comparing the American Joint Committee on Cancer (AJCC) breast cancer staging eighth versus seventh edition and breast cancer biology in large databases.

Jessica S. Young


Correlation analysis of radiotherapy and prognosis of elderly patients with hormone receptor-positive breast cancer in different immunohistochemical subtyping.

Jin Zhang


Correlation between TopIIα and ki-67 expression in tumors of luminal, primary operable breast cancer without HER2/neu overexpression in postmenopausal women as a prognostic factor.

Elena P. Ulianova


Does the innovative 4R Care Delivery Model improve timing and sequencing of guideline recommended breast cancer care in safety net and non-safety net centers?

Christine B. Weldon


Effectiveness of scalp cooling in reducing chemotherapy-induced alopecia: A single center prospective study in Lebanon.

Nour Haidar


Evaluation of immunotherapy (I-O)-associated immune cell (IC) dynamics and PD-L1 expression using multispectral immunohistochemistry (mIHC) and single-cell hierarchical regression modeling in early-stage breast cancer (ESBC).

Katherine Sanchez


Gene expression comparison between primary triple-negative breast cancer and matched axillary lymph node metastasis.

Marissa K. Srour


HIF1A genetic variability and late adverse events of radiotherapy in breast cancer.

Tanja Marinko


Impact of surgery type on survival in breast cancer patients.

Phuong Tuyet Ngo


Influence of radiation therapy on the outcome of T1-2N0M0 triple-negative breast cancer: A SEER population-based retrospective analysis.

Xiaoxiang Guan


KEYNOTE-756: Randomized, double-blind, phase 3 study of pembrolizumab vs placebo combined with neoadjuvant chemotherapy and adjuvant endocrine therapy for high-risk, early-stage estrogen receptor–positive, human epidermal growth factor receptor 2–negative (ER+/HER2−) breast cancer.

Fatima Cardoso


No relationship of axillary total tumor load (TTL) by PCR (OSNA) in early breast cancer and local and distant clinical outcomes.

Jose Ales-Martinez


NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

Eleftherios P. Mamounas


Patient-reported outcomes (PROs) in NRG oncology/NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) in stage 0, I, or II breast cancer.

Patricia A. Ganz


Prediction of occult axillary metastases in treatment-naïve patients with breast cancer: A transSENTINA analysis.

Cornelia Kolberg-Liedtke


Preoperative conventional axillary ultrasound (AUS) and sonoelastography (SE) for predicting axillary lymph node metastasis in breast cancer patients.

Alexander Petrovsky


Risk stratification in earl- stage luminal breast cancer patients treated with and without RT.

Charlotta Wadsten


Screening for cancer-related distress among women with newly diagnosed breast cancer (BC).

Lauren Z. Rynar


TARGIT E(lderly): Prospective phase II trial of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer.

Frederik Wenz


The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA).

Chizuko Kanbayashi


Time to surgery and overall survival after breast cancer diagnosis in a universal health system.

Yvonne L Eaglehouse


Ultrasound-guided dual-localization for axillary nodes before and after neoadjuvant chemotherapy with clip and activated charcoal in breast cancer patients: A feasibility study.

Yee Soo Chae